In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Amyris Inc. (NASDAQ:AMRS) reported that Dsm International B.v. has picked up 7,936,232 of common stock as of 2017-07-17.
The acquisition brings the aggregate amount owned by Dsm International B.v. to a total of 7,936,232 representing a 27.7% in the company.
For those not familiar with the company, Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.
A glance at Amyris Inc. (NASDAQ:AMRS)’s key stats reveals a current market capitalization of 78.27 Million based on 19.81 Million shares outstanding and a price at last close of $3.67 per share.
Looking at insider activity, there are a few recent transactions worth noting.
Specifically, on 2017-05-19, Yang picked up 100,000 at a purchase price of $0.29. This brings their total holding to 353,000 as of the date of the filing.
On the sell side, the most recent transaction saw Maxwell unload 313,649 shares at a sale price of $0.51. This brings their total holding to 49,538,771.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Amyris Inc. (NASDAQ:AMRS) as things move forward to see if its progress aligns with these transactions.Subscribe below and we’ll keep you on top of what’s happening before it moves markets.